Scientists reveal that a molecule normally used by the immune system to prevent excessive damage may actually contribute to chronic white matter injury.
Browsing: Immune disorders and inflammation
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Doris Doudet to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson’s disease rat model.
This study measures severities of depression, anxiety and stress, and compares them to the used disease-modifying treatment.
Although exercise training has been advocated as a nonpharmacological treatment for multiple sclerosis-related fatigue, no consensus exists regarding its effectiveness.
Researchers have demonstrated significant reductions in levels of fatigue for multiple sclerosis patients in a randomized trial assessing transcranial direct current stimulation.
Novel research has suggested the gut microbiome is involved in multiple sclerosis and could be a treatment target.
Researchers from Japan have revealed a new neural pathway that links stress with organ dysfunction.
October babies are more likely to develop the syndrome, according to a study presented at the Congress of the European Academy of Neurology (Amsterdam, The Netherlands).
Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.